Crystal structure analysis of Bis{(N,N′‐dimethylformamide)‐[μ‐bis‐N,N′‐(2‐oxybenzyl)‐1,3‐propanediaminato](μ‐asetato) nickel(II)}nickel(II)

The title compound, a homotrinuclear Ni^II complex has been synthesized from ONNO type Schiff base reduced with the help of NaBH₄. The structure of the complex, [Ni{Ni(CH₃CO₂) (C₁₇H₂₀N₂O₂) (C₃H₇NO)}₂], was identified using elemental analysis, thermal analysis, IR spectroscopy and x‐ray diffraction techniques. It was established that although some bond lengths and angles changed with respect to previous complexes, the Ni…Ni distance was approximately the same.     

LC Method with Precolumn Derivatization for Analysis of Mexiletine in Pharmaceutical Preparations

A isocratic, selective and accurate LC method of analysis of mexiletine in pharmaceutical preparations has been developed and validated. The method is based on derivatization of mexiletine with 4-chloro-7-nitrobenzofurazan in pH 9.0 borate buffer to yield a yellow product. Chromatography was performed on a C₁₈ column (150 × 4.6 mm i.d.) with acetonitrile–water 80:20 (v/v) as mobile phase at a flow rate of 1.0 mL min^?1. UV–visible absorbance detection was performed at 458 nm. The retention time of the mexiletine derivative was 4.10 min, and response was a linear function of concentration in the range 0.5–4.0 μg mL^?1 (r = 0.9998). The limits of detection and quantification were 0.05 and 0.15 μg mL^?1, respectively. Method validation revealed precision, sensitivity, and robustness were acceptable. Low RSD values are indicative of high precision, and high recovery values are indicative of the accuracy of the method. Results obtained by use of the proposed method for analysis of the mexiletine content of pharmaceutical a preparation were compared with those obtained by use of the official method. The method has been used for analysis of pharmaceutical preparations.     

Rapid and sensitive spectrofluorimetric determination of enrofloxacin, levofloxacin and ofloxacin with 2,3,5,6-tetrachloro-p-benzoquinone

A highly sensitive spectrofluorimetric method was developed for the first time, for the analysis of three fluoroquinolones (FQ) antibacterials, namely enrofloxacin (ENR), levofloxacin (LEV) and ofloxacin (OFL) in pharmaceutical preparations through charge transfer (CT) complex formation with 2,3,5,6-tetrachloro-p-benzoquinone (chloranil,CLA). At the optimum reaction conditions, the FQ–CLA complexes showed excitation maxima ranging from 359 to 363 nm and emission maxima ranging from 442 to 488 nm.Rectilinear calibration graphs were obtained in the concentration range of 50–1000, 50–1000 and 25–500 ng mL⁻¹ for ENR, LEV and OFL, respectively.The detection limit was found to be 17 ng mL⁻¹ for ENR, 17 ng mL⁻¹ for LEV, 8 ng mL⁻¹ for OFL, respectively. Excipients used as additive in commercial formulations did not interfere in the analysis. The method was validated according to the ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. The proposed method was successfully applied to the analysis of pharmaceutical preparations. The results obtained were in good agreement with those obtained using the official method; no significant difference in the accuracy and precision as revealed by the accepted values of t- and F-tests, respectively.     

Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations

Simple, rapid and highly sensitive spectrofluorimetric method is presented for the determination of four fluoroquinolone (FQ) drugs, ciprofloxacin, enoxacin, norfloxacin and moxifloxacin in pharmaceutical preparations. Proposed method is based on the derivatization of FQ with 4-chloro-7-nitrobenzofurazan (NBD-Cl) in borate buffer of pH 9.0 to yield a yellow product. The optimum experimental conditions have been studied carefully. Beer's law is obeyed over the concentration range of 23.5-500 ng mL(-1) for ciprofloxacin, 28.5-700 ng mL(-1) for enoxacin, 29.5-800 ng mL(-1) for norfloxacin and 33.5-1000 ng mL(-1) for moxifloxacin using NBD-Cl reagent, respectively. The detection limits were found to be 7.0 ng mL(-1) for ciprofloxacin, 8.5 ng mL(-1) for enoxacin, 9.2 ng mL(-1) for norfloxacin and 9.98 ng mL(-1) for moxifloxacin, respectively. Intra-day and inter-day relative standard deviation and relative mean error values at three different concentrations were determined. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed methods. The method is highly sensitive and specific. The results obtained are in good agreement with those obtained by the official and reference method. The results presented in this report show that the applied spectrofluorimetric method is acceptable for the determination of the four FQ in the pharmaceutical preparations. Common excipients used as additives in pharmaceutical preparations do not interfere with the proposed method.     

How far can relaxation functions be increasing in viscoelastic problems?

It is known that when we add a viscoelastic damping to a frictional damping acting in the domain we might lose the property of exponential stability of the system. Moreover, a necessary condition for a system to be sub-exponentially stable is that the kernel itself must be sub-exponentially decaying to zero. Having this in mind, a natural question to be asked is that of when this necessary condition is also sufficient. We prove that this is the case for a fairly large class of kernels.     

Structural,Optical and Electrochromic Properties of WO_3 Thin Films Prepared by Chemical Spray Pyrolysis Versus Spin Coating Technique

In this study, Tungsten Oxide (WO₃) thin films were prepared by Chemical Spray Pyrolysis (CSP) and Spin Coating (SC) techniques and it was investigated effects of technique and parameter on the films. WO₃ thin films were deposited on ITO (Indium Tin Oxide) coated glasses. The structural, optical and electrochromic properties of the WO₃ thin films were characterized by XRD, SEM, UV, and CV measurements. The sharpest (200) peak was observed in the XRD spectra and optical band gaps were calculated around 2.6～3.1 eV via UV-Vis spectra for all of the samples. Micro fibrous reticulated surface (filamentous like) morphology for the films deposited by CSP technique and smooth surface morphology with high optical transmittance for the film deposited by SC Technique were obtained from SEM images. In addition to these results, it was revealed that all the samples exhibit good electrochromic performance.     

Phenolic compounds from Scorzonera latifolia (Fisch. & Mey.) DC

A new 3-benzylphthalide, scorzoveratrin 4'-O-β-glucoside (1), together with the known 3-benzylphthalides, scorzoveratrin (2) and scorzoveratrozit (3), the caffeoyl derivatives, chlorogenic acid methyl ester (4), 4,5-dicaffeoylquinic acid (5), 4,5-dicaffeoylquinic acid methyl ester (6), 3,5-dicaffeoylquinic acid (7) and caffeic acid (8) were isolated from the subaerial parts of Scorzonera latifolia (Fisch. & Mey.) DC. All secondary metabolites were assigned using physicochemical and spectroscopic data. The known compounds 2-8 were isolated for the first time from this species.     

新型二氧代氮杂茂并[3’,4’-d]N-甲基异噁唑四氯化铁酸盐衍生物的合成及其生物活性

硫酸二甲酯作为N-甲基化试剂,与相应的异噁唑啉反应,并在盐酸中三氯化铁作为阴离子交换试剂,合成了15个未见文献报道的2-甲基-3-(1’,2’-二-O-环亚己基二氧乙基)-5-芳基-3a,6a-二氢-4,6-二氧代氮杂茂并[3’,4’-d]异噁唑四氯化铁酸盐衍生物4a～4o.化合物4a～4o结构结构经1H NMR,IR和元素分析确证,并进行了初步药物活性筛选,大部分化合物显示了不同程度的抗癌和抗炎症性及免疫性疾病活性.体外抗癌活性试验表明,当样品浓度为20μg/mL时,除了4h无活性外,其余化合物对细胞分裂周期磷酸酯酶Cdc25B的抑制率为≥97.55%.此外,体外白细胞共同抗原活性试验表明,当样品浓度为20μg/mL时,所有化合物4a～4o对白细胞共同抗原CD45蛋白酪氨酸磷酸酶A具有良好的抑制活性,其抑制率为68.41%～93.38%.在此基础上,初步讨论了该类化合物的构效关系.     

In Vitro Inhibition Effect of Some Dihydroxy Coumarin Compounds on Purified Human Serum Paraoxonase 1 (PON1)

Human serum paraoxonase 1 (PON1; EC 3.1.8.1) is a high-density lipoprotein associated, calcium-dependent enzyme that hydrolyses aromatic esters, organophosphates and lactones and can protect the low-density lipoprotein against oxidation. In this study, in vitro inhibition effect of some dihydroxy coumarin compounds namely 6,7-dihydroxy-3-(2-methylphenyl)-2H-chromen-2-one (A), 6,7-dihydroxy-3-(3-methylphenyl)-2H-chromen-2-one (B) and 6,7-dihydroxy-3-(4-methylphenyl)-2H-chromen-2-one (C) on purified PON1 were investigated by using paraoxon as a substrate. PON1 was purified using two-step procedures, namely ammonium sulphate precipitation and Sepharose-4B-l-tyrosine-1-naphthylamine hydrophobic interaction chromatography. The purified enzyme had a specific activity of 11.76?U/mg. The dihydroxy coumarin derivatives of A and B compounds inhibited PON1 enzyme activity in a noncompetitive inhibition manner with K _i of 0.0080?±?0.256 and 0.0003?±?0.018?mM values, respectively. C compound exerted an uncompetitive inhibition of PON1 enzyme activity with K _i of 0.0010?±?0.173?mM. Moreover, dihydroxy coumarin derivatives of A, B and C compounds were effective inhibitors on purified human serum PON1 activity with IC₅₀ of 0.012, 0.022 and 0.003?mM values, respectively. IC₅₀ value of unsubstituted 6,7 dihydroxy coumarin was found as 0.178?mM. The present study has demonstrated that PON1 activity is very highly sensitive to studied coumarin derivatives.